Fructus aurantii reduced portal pressure in portal hypertensive rats.
The purpose of this study was to investigate the effects of Fructus Aurantii (the unripe fruits of Citrus aurantium L.) on portal hypertensive rats. Portal hypertension was induced by partial portal vein ligation (PVL) in Sprague-Dawley rats. Sham-operated (Sham) rats served as controls. Hemodynamic and in vitro contractile studies were performed at 14 days after surgery. Both the aqueous extract of Fructus Aurantii and synephrine, one of its purified principles with pressor activity, were infused into the conscious PVL and Sham rats via a syringe pump. Fructus Aurantii (1.25, 2.5, & 5.0 mg/kg/min) dose-dependently reduced portal pressure in PVL and Sham rats, with the percentage change in portal pressure more pronounced in PVL rats. Mean arterial pressure was dose-dependently elevated by Fructus Aurantii. Synephrine (0.095, 0.19, & 0.38 mg/kg/min) also dose-dependently reduced portal pressure and elevated mean arterial pressure in PVL and Sham rats. Fructus Aurantii (2.8-280 micrograms/ml) induced dose-dependent contractile responses mainly in aorta and mesenteric artery, but little response in portal vein. The results showed that Fructus Aurantii infusion reduced portal pressure, possibly by way of arterial vasoconstriction.
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002957:Citrus; D004305:Dose-Response Relationship, Drug; D006975:Hypertension, Portal / Q000188:drug therapy*; D066298:In Vitro Techniques; D008297:Male; D008516:Medicine, Chinese Traditional; D008517:Phytotherapy; D051381:Rats; D017207:Rats, Sprague-Dawley; D013578:Synephrine / Q000627:therapeutic use; D014661:Vasoconstriction / Q000187:drug effects
D000959:Antihypertensive Agents; D013578:Synephrine